Stock Analysis of Oncorus Inc (ONCR) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ONCR
Close 0.126
Change -0.0040 / 3.08 %
Volume 135947
Vol Change -32857.00 / 19.46 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bullish
Growth Index Low Growth Stock
Value Index Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index Very Low Stability Stock


Fundamental View of Oncorus Inc
PE (TTM)

-0.0252

Very Poor
Price / Book

0.0426

Excellent
Price / Sales

0

Very Poor
Piotroski F Score

1.0

Very Poor
Market Cap

3287.94 K

Enterprise Value

-21292.06 K

ROA (TTM)

-83.33

Very Poor
ROE (TTM)

-169.05

Very Poor
Net Margin (TTM)

0

Poor
Revenue

%

0
Net Profit

19.55 %

-77422.00 K
Debt to Equity

0.0187

Excellent
Altman Z Score

-4.10

Very Poor
Quick Ratio

0

Poor
Cash Ratio

1.67

Indecisive


Highs/Lows of Oncorus Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.013 869.23 % 1.54 % 0.20.01329-Dec-2327-Dec-23
Two Week0.012 950.00 % 3.42 % 0.20.01229-Dec-2318-Dec-23
One Month0.021 500.00 % 5.60 % 0.20.0129-Dec-2308-Dec-23
Three Month0.0284 343.66 % 5.95 % 0.20.0129-Dec-2308-Dec-23
Six Months0.0362 248.07 % 17.48 % 0.20.0129-Dec-2308-Dec-23
One year0.255 50.59 % 27.52 % 0.470.0103-Feb-2308-Dec-23
Two year5.09 97.52 % 29.70 % 1.90.0107-Jun-2208-Dec-23


Technical View of Oncorus Inc
RSI

89.34

Mild Bearish
MACD

0.0180

Mild Bullish
ADX

65.84

Strong Bullish
Super Trend

0.107

Bullish
Williams %R

-39.05

Strong Bearish
CCI

312.47

Mild Bearish


EMA 5

0.090

Strong Bullish
EMA 15

0.0492

Strong Bullish
EMA 50

0.0322

Strong Bullish
EMA 100

0.052

Strong Bullish
SMA 100

0.0284

Strong Bullish
SMA 200

0.124

Strong Bullish
SMA 5 / 20

0.076 / 0.0303

Strong Bullish
SMA 15 / 50

0.0334 / 0.0260

Strong Bullish
SMA 50 / 200

0.0260 / 0.124

Mild Bearish




Charts of Oncorus Inc


Returns of Oncorus Inc with Peers
Period / StockONCRADTXREVBAPVO
1 Week869.23%-2.90%-1.94%-10.11%
1 Mth500.00%-14.47%-6.05%12.28%
3 Mth343.66%-47.52%-27.08%-88.11%
6mth248.07%-42.57%-89.48%-90.43%
1 Year-50.59%-91.16%-93.59%-98.92%
2 Year-97.52%-99.63%-99.70%-99.62%
5 Years----99.84%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Oncorus Inc with Peers
Ratio / StockONCRADTXREVBAPVO
PE-0.0252-0.0401-0.100-0.0087
P/B0.04260.2580.0960.0162
ROA-83.33-162.60-59.51-101.21
ROE-169.05-642.04-96.62-186.21
Debt To Equity0.01871.0600
Revenue0
% 		749475
19.73 % 		0
% 		0
100.00 %
Net Income-77422.00 K
19.55 % 		-29595.79 K
7.04 % 		875063
108.11 % 		-16150.00 K
330.25 %


Technicals of Oncorus Inc with Peers
Technical / StockONCRADTXREVBAPVO-
ADX65.8413.259.7711.55
CMF0.529-0.207-0.289-0.341
MFI97.1327.5442.8390.79
RSI89.3434.2043.1331.93
MACD Abv SignalTrueTrueTrueTrue
Price Above 50 MATrueFalseFalseFalse-
Price Above 200 MATrueFalseFalseFalse-


About : Oncorus Inc

Address : 50 Hampshire Street, Cambridge, MA, United States, 02139
Tel : 857 320 6400
URL : https://www.oncorus.com
Code : ONCR, ISIN : US68236R1032, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 02_Oct_2020
Employee Count : 64

Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company develops ONCR-021 for the treatment of non-small cell lung cancer, renal cell carcinoma, melanoma, and anaplastic thyroid cancer; and ONCR-788 for the treatment of small cell lung cancer, neuroendocrine prostate, and other neuroendocrine cancers. Oncorus, Inc. was incorporated in 2015 and is headquartered in Andover, Massachusetts.


Note : All Data Generated at the End of Trading Hours (EOD Data)